Halozyme Therapeutics (HALO) Net Margin (2010 - 2026)
Halozyme Therapeutics (HALO) posted Net Margin of 47.80% for Q2 2026, down 2.91 percentage points from 50.71% a year earlier but up 7.97 percentage points from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Net Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Margin at Halozyme Therapeutics was 24.86%, down 22.42 percentage points year-over-year; for FY2025, it came in at 22.69%, down 21.05 percentage points from FY2024.
- Annual Net Margin shows a five-year change of -25.55 percentage points (FY2020 to FY2025).
- In prior years, Halozyme Therapeutics' Net Margin was 43.74% in FY2024 (+9.78 pp), 33.96% in FY2023 (+3.34 pp), 30.62% in FY2022 (-60.22 pp) and 90.84% in FY2021 (+42.60 pp).
- Quarterly Net Margin has run from a low of -31.34% in Q4 2025 to a high of 186.99% in Q3 2021 over five years.
- On a year-over-year basis, Net Margin has declined in each of the last three quarters, with an average year-over-year change of -6.10 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Net Margin in the past five years was Q3 2021, with a gain of 131.55 percentage points; the weakest was Q3 2022, with a drop of 157.49 percentage points.
- According to Business Quant data, Net Margin for the three prior quarters was 39.83% (Q1 2026), -31.34% (Q4 2025) and 49.46% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 32.99% |
| 10 | Halozyme Therapeutics | 12.72 Bn | 11.33 Bn | 401.83 Mn | 47.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.80% |
| Mar 31, 2026 | 39.83% |
| Dec 31, 2025 | -31.34% |
| Sep 30, 2025 | 49.46% |
| Jun 30, 2025 | 50.71% |
| Mar 31, 2025 | 44.59% |
| Dec 31, 2024 | 45.98% |
| Sep 30, 2024 | 47.23% |
| Jun 30, 2024 | 40.30% |
| Mar 31, 2024 | 39.22% |
| Dec 31, 2023 | 37.12% |
| Sep 30, 2023 | 37.88% |
| Jun 30, 2023 | 33.82% |
| Mar 31, 2023 | 24.43% |
| Dec 31, 2022 | 31.79% |
| Sep 30, 2022 | 29.49% |
| Jun 30, 2022 | 14.89% |
| Mar 31, 2022 | 51.25% |
| Dec 31, 2021 | 65.46% |
| Sep 30, 2021 | 186.99% |
API Access
Halozyme Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();